Two recent studies says that the popular arthritis drug Celebrex that cut the chances of developing precancerous growths called polyps by 33 percent to 45 percent in people can increase heart risk.
Read the rest of this entry »
Trials of Tykerb, a breast cancer drug targeting tumours that fail to respond to Herceptin have been stopped early because the treatment appears dramatically to improve patients’ chances of survival by decreasing the cancer growth.
Read the rest of this entry »
 |  |  |  |  |  |  |
 |  |  |  |  |  |  |
 |  |  |  |  |  |  |
 |  |  |  |  |  |  |
 |  |  |  |  | ||
| Plugin by Taragana | ||||||
| M | T | W | T | F | S | S |
|---|---|---|---|---|---|---|
| « Aug | ||||||
| 1 | 2 | 3 | 4 | 5 | 6 | 7 |
| 8 | 9 | 10 | 11 | 12 | 13 | 14 |
| 15 | 16 | 17 | 18 | 19 | 20 | 21 |
| 22 | 23 | 24 | 25 | 26 | 27 | 28 |
| 29 | 30 | |||||